Compare BNR & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | WALD |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 216.9M | 246.7M |
| IPO Year | 2020 | 2021 |
| Metric | BNR | WALD |
|---|---|---|
| Price | $35.50 | $1.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | 34.1K | ★ 59.8K |
| Earning Date | 11-20-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $75,749,382.00 | ★ $274,560,000.00 |
| Revenue This Year | $136.32 | $2.69 |
| Revenue Next Year | N/A | $10.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.56 | ★ 14.22 |
| 52 Week Low | $2.18 | $1.45 |
| 52 Week High | $41.72 | $4.10 |
| Indicator | BNR | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | 36.47 |
| Support Level | $35.00 | $1.45 |
| Resistance Level | $41.72 | $1.85 |
| Average True Range (ATR) | 3.51 | 0.13 |
| MACD | 0.75 | 0.02 |
| Stochastic Oscillator | 76.55 | 21.32 |
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.